Target intelligence / Profile preview

Ceramide 1 (Ceramide EOS)

Target
Ceramide EOS
Molecular classification
Other
01

Overview

Ceramide 1, also known as Ceramide EOS, is a critical sphingolipid component of the mammalian skin barrier, specifically the stratum corneum [31]. It is characterized by an omega-hydroxy fatty acid that is ester-linked to another fatty acid (typically linoleic acid) and amide-linked to a sphingosine base [31]. This unique structure allows Ceramide 1 to act as a molecular rivet, bridging lipid lamellae and maintaining the structural integrity of the skin's permeability barrier [31]. Deficiencies in Ceramide 1 are strongly associated with skin disorders such as atopic dermatitis, psoriasis, and ichthyosis [24]. While not a traditional therapeutic target like a receptor or enzyme, it is a key active ingredient in dermatological treatments aimed at restoring skin barrier function and preventing transepidermal water loss [31]. In signaling contexts, the term is sometimes confused with Ceramide-1-phosphate (C1P), a bioactive lipid that regulates cell survival and inflammation through a putative G protein-coupled receptor [1, 2].

Other names
Ceramide EOSEOS ceramideN-(omega-acyloxy)acylsphingosineCeramide 1-phosphate (misnomer)
02

Mechanism of action

Restoration of the skin's lipid barrier and improvement of hydration by replenishing essential sphingolipids in the stratum corneum [31].

03

Biological functions

Skin barrier maintenanceWater retentionCell signalingStructural integrity of stratum corneum
04

Disease associations

Atopic dermatitisPsoriasisIchthyosisXerosis
05

Safety considerations

Low systemic toxicityPotential for skin irritation in specific formulationsComedogenicity in certain skin types
06

Interacting drugs

Topical ceramides

2 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL)Stratum corneum ceramide levelsSkin hydration index

Beyond the preview

Go deeper on Ceramide 1 (Ceramide EOS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ceramide 1 (Ceramide EOS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call